Skip to main content

Head-to-head comparison

new england biolabs vs amgen

amgen leads by 20 points on AI adoption score.

new england biolabs
Life sciences research tools · ipswich, massachusetts
62
D
Basic
Stage: Exploring
Key opportunity: AI can accelerate novel enzyme discovery and optimization, reducing R&D timelines and costs while creating new high-value products for synthetic biology and diagnostics.
Top use cases
  • Protein Function Prediction
  • Lab Process Automation
  • Demand Forecasting
View full profile →
amgen
Biotechnology & pharmaceuticals · thousand oaks, california
82
B
Advanced
Stage: Mature
Key opportunity: AI can dramatically accelerate drug discovery and clinical trial design by predicting protein structures, identifying novel therapeutic targets, and optimizing patient recruitment, potentially cutting years and billions from R&D timelines.
Top use cases
  • AI-Powered Drug Discovery
  • Clinical Trial Optimization
  • Predictive Maintenance in Manufacturing
View full profile →
vs

Want a private comparison report?

We'll benchmark your company against up to 5 peers with a detailed AI adoption assessment.

Request report →